Reproducibility and transparency characteristics of oncology research evidence
暂无分享,去创建一个
Daniel Tritz | Matt Vassar | Cole Wayant | Michael Warren | Nam Vo | Corbin Walters | Zachery J Harter | Justin Chronister | M. Vassar | C. Wayant | Zachery J. Harter | Nam Vo | Michael Warren | Justin Chronister | D. Tritz | Corbin G Walters
[1] J. Ioannidis. Why Most Published Research Findings Are False , 2005, PLoS medicine.
[2] A. Hrõbjartsson,et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.
[3] John P. A. Ioannidis,et al. Reproducible Research Practices and Transparency across the Biomedical Literature , 2016, PLoS biology.
[4] C. Begley,et al. Drug development: Raise standards for preclinical cancer research , 2012, Nature.
[5] David J Torgerson,et al. Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals , 2005, BMJ : British Medical Journal.
[6] Melissa S. Anderson,et al. Extending the Mertonian Norms: Scientists' Subscription to Norms of Research , 2010, The Journal of higher education.
[7] B. Gyawali,et al. Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival , 2019, JAMA network open.
[8] R. Nuzzo. How scientists fool themselves – and how they can stop , 2015, Nature.
[9] Bradley Voytek,et al. The Virtuous Cycle of a Data Ecosystem , 2016, PLoS Comput. Biol..
[10] Zach Hensel,et al. On the value of preprints: An early career researcher perspective , 2018, PLoS biology.
[11] Jenine K. Harris,et al. Use of reproducible research practices in public health: A survey of public health analysts , 2018, PloS one.
[12] Tim Errington,et al. Reproducibility Project: Cancer Biology , 2013 .
[13] Susan Mallett,et al. A systematic review classifies sources of bias and variation in diagnostic test accuracy studies. , 2013, Journal of clinical epidemiology.
[14] C. Begg,et al. Publication bias and dissemination of clinical research. , 1989, Journal of the National Cancer Institute.
[15] E. von Elm,et al. Full publication of results initially presented in abstracts. , 2007, The Cochrane database of systematic reviews.
[16] Francis Tuerlinckx,et al. Increasing Transparency Through a Multiverse Analysis , 2016, Perspectives on psychological science : a journal of the Association for Psychological Science.
[17] J. Kaiser. Plan to replicate 50 high-impact cancer papers shrinks to just 18 , 2018, Science.
[18] I. Cockburn,et al. The Economics of Reproducibility in Preclinical Research , 2015, PLoS biology.
[19] M. Baker. 1,500 scientists lift the lid on reproducibility , 2016, Nature.
[20] L. V. van Amelsvoort,et al. False positive outcomes and design characteristics in occupational cancer epidemiology studies. , 2001, International journal of epidemiology.
[21] R. Kaplan,et al. Likelihood of Null Effects of Large NHLBI Clinical Trials Has Increased over Time , 2015, PloS one.
[22] F. Prinz,et al. Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.
[23] P. Glasziou,et al. Avoidable waste in the production and reporting of research evidence , 2009, The Lancet.
[24] G. Pond,et al. Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: a systematic review. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] M. Vassar,et al. Evidence of selective reporting bias in hematology journals: A systematic review , 2017, PloS one.
[26] Brian A. Nosek,et al. An open investigation of the reproducibility of cancer biology research , 2014, eLife.
[27] A. Joffe,et al. The methodological quality of animal research in critical care: the public face of science , 2014, Annals of Intensive Care.
[28] J. Ioannidis,et al. Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017 , 2018, PLoS biology.
[29] Roger D. Peng,et al. The reproducibility crisis in science: A statistical counterattack , 2015 .
[30] Carl Heneghan,et al. What is missing from descriptions of treatment in trials and reviews? , 2008, BMJ : British Medical Journal.
[31] A. Hrõbjartsson,et al. Promoting public access to clinical trial protocols: challenges and recommendations , 2018, Trials.
[32] S. Vazire. Quality Uncertainty Erodes Trust in Science , 2017 .
[33] J. Ioannidis. Why Science Is Not Necessarily Self-Correcting , 2012, Perspectives on psychological science : a journal of the Association for Psychological Science.
[34] R. Peng. Reproducible Research in Computational Science , 2011, Science.
[35] Mallory C. Kidwell,et al. An empirical assessment of transparency and reproducibility-related research practices in the social sciences (2014–2017) , 2019, Royal Society Open Science.
[36] David Moher,et al. Comparison of registered and published primary outcomes in randomized controlled trials. , 2009, JAMA.
[37] J. Celis,et al. A mission‐oriented approach to cancer in Europe: a joint mission/vision 2030 , 2017, Molecular oncology.
[38] A. Liberati. An unfinished trip through uncertainties , 2004, BMJ : British Medical Journal.
[39] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.
[40] Zhen Wang,et al. Guidelines for reporting meta-epidemiological methodology research , 2017, Evidence-Based Medicine.